List of Chapters/Sections(Table Of Content)
1 Dystrophin Market Overview
1.1 Product Overview and Scope of Dystrophin
1.2 Dystrophin Segment by Type
1.2.1 Global Dystrophin Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 DS-5141
1.2.3 Biostrophin
1.2.4 BMBD-001
1.2.5 NS-065
1.2.6 Others
1.3 Dystrophin Segment by Application
1.3.1 Global Dystrophin Sales Comparison by Application: (2022-2028)
1.3.2 Genetic Disorders
1.3.3 Musculoskeletal Disorders
1.3.4 Others
1.4 Global Dystrophin Market Size Estimates and Forecasts
1.4.1 Global Dystrophin Revenue 2017-2028
1.4.2 Global Dystrophin Sales 2017-2028
1.4.3 Dystrophin Market Size by Region: 2017 Versus 2021 Versus 2028
2 Dystrophin Market Competition by Manufacturers
2.1 Global Dystrophin Sales Market Share by Manufacturers (2017-2022)
2.2 Global Dystrophin Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Dystrophin Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Dystrophin Manufacturing Sites, Area Served, Product Type
2.5 Dystrophin Market Competitive Situation and Trends
2.5.1 Dystrophin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Dystrophin Players Market Share by Revenue
2.5.3 Global Dystrophin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dystrophin Retrospective Market Scenario by Region
3.1 Global Dystrophin Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Dystrophin Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Dystrophin Market Facts & Figures by Country
3.3.1 North America Dystrophin Sales by Country
3.3.2 North America Dystrophin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dystrophin Market Facts & Figures by Country
3.4.1 Europe Dystrophin Sales by Country
3.4.2 Europe Dystrophin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dystrophin Market Facts & Figures by Region
3.5.1 Asia Pacific Dystrophin Sales by Region
3.5.2 Asia Pacific Dystrophin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dystrophin Market Facts & Figures by Country
3.6.1 Latin America Dystrophin Sales by Country
3.6.2 Latin America Dystrophin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Dystrophin Market Facts & Figures by Country
3.7.1 Middle East and Africa Dystrophin Sales by Country
3.7.2 Middle East and Africa Dystrophin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Dystrophin Historic Market Analysis by Type
4.1 Global Dystrophin Sales Market Share by Type (2017-2022)
4.2 Global Dystrophin Revenue Market Share by Type (2017-2022)
4.3 Global Dystrophin Price by Type (2017-2022)
5 Global Dystrophin Historic Market Analysis by Application
5.1 Global Dystrophin Sales Market Share by Application (2017-2022)
5.2 Global Dystrophin Revenue Market Share by Application (2017-2022)
5.3 Global Dystrophin Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Asklepios BioPharmaceutical Inc
6.1.1 Asklepios BioPharmaceutical Inc Corporation Information
6.1.2 Asklepios BioPharmaceutical Inc Description and Business Overview
6.1.3 Asklepios BioPharmaceutical Inc Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Asklepios BioPharmaceutical Inc Dystrophin Product Portfolio
6.1.5 Asklepios BioPharmaceutical Inc Recent Developments/Updates
6.2 BioMarin Pharmaceutical Inc
6.2.1 BioMarin Pharmaceutical Inc Corporation Information
6.2.2 BioMarin Pharmaceutical Inc Description and Business Overview
6.2.3 BioMarin Pharmaceutical Inc Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.2.4 BioMarin Pharmaceutical Inc Dystrophin Product Portfolio
6.2.5 BioMarin Pharmaceutical Inc Recent Developments/Updates
6.3 Daiichi Sankyo Company Ltd
6.3.1 Daiichi Sankyo Company Ltd Corporation Information
6.3.2 Daiichi Sankyo Company Ltd Description and Business Overview
6.3.3 Daiichi Sankyo Company Ltd Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Daiichi Sankyo Company Ltd Dystrophin Product Portfolio
6.3.5 Daiichi Sankyo Company Ltd Recent Developments/Updates
6.4 Editas Medicine Inc
6.4.1 Editas Medicine Inc Corporation Information
6.4.2 Editas Medicine Inc Description and Business Overview
6.4.3 Editas Medicine Inc Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Editas Medicine Inc Dystrophin Product Portfolio
6.4.5 Editas Medicine Inc Recent Developments/Updates
6.5 Genethon SA
6.5.1 Genethon SA Corporation Information
6.5.2 Genethon SA Description and Business Overview
6.5.3 Genethon SA Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Genethon SA Dystrophin Product Portfolio
6.5.5 Genethon SA Recent Developments/Updates
6.6 Nippon Shinyaku Co Ltd
6.6.1 Nippon Shinyaku Co Ltd Corporation Information
6.6.2 Nippon Shinyaku Co Ltd Description and Business Overview
6.6.3 Nippon Shinyaku Co Ltd Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Nippon Shinyaku Co Ltd Dystrophin Product Portfolio
6.6.5 Nippon Shinyaku Co Ltd Recent Developments/Updates
6.7 Pfizer Inc
6.6.1 Pfizer Inc Corporation Information
6.6.2 Pfizer Inc Description and Business Overview
6.6.3 Pfizer Inc Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Pfizer Inc Dystrophin Product Portfolio
6.7.5 Pfizer Inc Recent Developments/Updates
6.8 Sarepta Therapeutics Inc
6.8.1 Sarepta Therapeutics Inc Corporation Information
6.8.2 Sarepta Therapeutics Inc Description and Business Overview
6.8.3 Sarepta Therapeutics Inc Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Sarepta Therapeutics Inc Dystrophin Product Portfolio
6.8.5 Sarepta Therapeutics Inc Recent Developments/Updates
6.9 WAVE Life Sciences Ltd
6.9.1 WAVE Life Sciences Ltd Corporation Information
6.9.2 WAVE Life Sciences Ltd Description and Business Overview
6.9.3 WAVE Life Sciences Ltd Dystrophin Sales, Revenue and Gross Margin (2017-2022)
6.9.4 WAVE Life Sciences Ltd Dystrophin Product Portfolio
6.9.5 WAVE Life Sciences Ltd Recent Developments/Updates
7 Dystrophin Manufacturing Cost Analysis
7.1 Dystrophin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dystrophin
7.4 Dystrophin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dystrophin Distributors List
8.3 Dystrophin Customers
9 Dystrophin Market Dynamics
9.1 Dystrophin Industry Trends
9.2 Dystrophin Market Drivers
9.3 Dystrophin Market Challenges
9.4 Dystrophin Market Restraints
10 Global Market Forecast
10.1 Dystrophin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dystrophin by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Dystrophin by Type (2023-2028)
10.2 Dystrophin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dystrophin by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Dystrophin by Application (2023-2028)
10.3 Dystrophin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dystrophin by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Dystrophin by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
